Hypertension (HT) is one of the most important known risk factors for atherosclerosis. HT can initiate the atherosclerotic process alone and can also accelerate the atherosclerotic process by ...

A new study demonstrates the potential of extending peptide receptor radionuclide therapy targeting the somatostatin receptor to other types of malignancies beyond neuroendocrine tumors. A study ...

Palsonify, a once-daily oral SST2 agonist, offers a noninvasive alternative to monthly depot injections, long considered the standard medical therapy for acromegaly.

INTRODUCTION sST2 protein is a new biomarker. Its prognostic value in chronic heart failure (CHF) is still unclear. OBJECTIVES The aim of the study was to evaluate the value of sST2 protein in ...

Overexpression of the ErbB2 receptor tyrosine kinase in breast cancer contributes to tumor development and is associated with poor prognosis. However, the mechanism by which ErbB2 might contribute to ...

The concordance of estrogen and progesterone receptor status (ER-PR) and HER2/neu expression in DCIS coexistent with micro-invasive and invasive carcinoma. Background: Previous analyses have ...

In our study, concentrations of both Gal-3 and sST2 were higher in those with worse clinical presentation at baseline. Both Gal-3 and sST2 were associated with unfavorable in-hospital outcomes and ...

5-FU/leucovorin (5FU/LV) combined with irinotecan (CPT-11) and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma. Background: Previous analyses ...

Researchers have identified a blood protein that plays a key role in the pathogenesis of Alzheimer's disease (AD). Their findings reveal an innovative strategy in reducing the risk of AD development ...

Reston, Va. - A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential of extending peptide receptor radionuclide therapy targeting the somatostatin ...